Antiplatelet Therapy

JUL 13, 2026 · JOURNAL ARTICLE

Impact of dual antiplatelet therapy duration after percutaneous coronary intervention on outcomes in acute coronary syndrome patients with and without chronic kidney disease: a nationwide cohort study.

Renal Failure

Observational cohort study with a large sample (4,800 patients) from a national database showing no benefit of prolonged DAPT on cardiovascular outcomes in ACS patients, but identifying a signal of increased bleeding in CKD subgroup; findings are exploratory and require confirmation.

APR 14, 2026 · JOURNAL ARTICLE

Prognostic implications of single antiplatelet therapy in individuals developing diabetic foot disease with concurrent peripheral arterial disease.

Annals of Medicine

Observational comparative effectiveness study with IPTW adjustment showing aspirin associated with lower mortality than alternatives in diabetic PAD patients with foot disease, but findings are from registry data without randomization and require prospective verification.